Austin J. Combest - Concepedia

Author

Austin J. Combest

University of North Carolina at Chapel Hill

Also Known As

A. Combest, A. J. Combest, Austin Combest, Austin J Combest, Austin J. Combest, Austin James Combest, Combest, Austin J., Rosen, Jeffrey M., Sharpless, Norman E.

Publications

705

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center Carlow University University of North Carolina Health Care

About

Austin J. Combest is an author at University of North Carolina at Chapel Hill specializing in pharmacotherapy, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	60
2	Pharmacology	2	2	48
3	Nephrology	1	1	29
4	Obstetrics	1	1	12
5	Cancer Therapeutics	1	1	12

Austin J. Combest

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy Patrick J. Roberts, John Bisi, Jay C. Strum, JNCI Journal of the National Cancer Institute	2012	249
Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models Patrick J. Roberts, Jerry Usary, David B. Darr, Clinical Cancer Research	2012	135
Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors Vivek Subbiah, Juneko E. Grilley‐Olson, Austin J. Combest, Clinical Cancer Research	2017	107
Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice Jerry Usary, Wei Zhao, David B. Darr, Clinical Cancer Research	2013	55
Genetically Engineered Cancer Models, But Not Xenografts, Faithfully Predict Anticancer Drug Exposure in Melanoma Tumors Austin J. Combest, Patrick J. Roberts, Patrick M. Dillon, The Oncologist	2012	36
Effects of herbal supplements on the kidney. Wendell L. Combest, Marian Newton, Austin J. Combest, PubMed Renal InflammationDialysis TherapyPharmacotherapyHerbal SupplementsRenal Function	2005	29
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients Christine M. Walko, Austin J. Combest, Ivan Spasojević, Cancer Chemotherapy and Pharmacology Breast Cancer PatientsMedicinePharmacologyBreast CancerPharmacotherapy	2012	19
Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD Ronald de Wit, Stephen J. Freedland, Stéphane Oudard, Prostate Cancer and Prostatic Diseases	2022	14
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer William C. Zamboni, Austin J. Combest, Julie A. DeLoia, Cancer Chemotherapy and Pharmacology Phenotypic StudyMedicinePrimary Peritoneal CancerGynecologyPharmacotherapy	2011	12
Alternative statistical strategies for biosimilar drug development Austin J. Combest, Song Wang, Brian T Healey, Generics and Biosimilars Initiative Journal	2014	12

Page 1